New blood tests for acute pulmonary embolism
Part of Blood & lymphatic, Heart & circulation, Lungs & breathing clinical trials.
This study tests new blood markers to help diagnose and treat acute pulmonary embolism (a blood clot in the lung). It is for adults who are being diagnosed for the first time with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are being newly diagnosed with acute pulmonary embolism (blood clot in the lung) using a special CT scan
- You have not taken any blood-thinning medication in the past month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood test results and CT scan findings in people who have just been diagnosed with a blood clot in the lung. Researchers want to understand which tests best predict how serious the clot is and how patients will recover.
This research study tests a special chest CT scan to help diagnose acute pulmonary embolism—a blood clot that suddenly blocks blood flow in your lungs. You may qualify if you're already getting a CT scan for suspected lung clots and meet basic health requirements.
This study tests a new, non-invasive imaging method called pulsatile electrical impedance tomography (EIT) to help diagnose and monitor acute pulmonary embolism (blood clots in the lungs). It may provide a faster or safer way to detect clots compared to standard CT scans, especially for patients who cannot have contrast dye.
This study examines how red blood cell counts and heart function relate in patients with pulmonary embolism (a blood clot in the lungs). Understanding these connections may help doctors better assess severity and guide treatment decisions.
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
This trial is for people who had a pulmonary embolism (a blood clot in the lungs) in the last 3 to 12 months and are still on blood thinners. It aims to find early signs of a serious condition called CTEPH (chronic blood clots in the lungs) so treatment can start sooner.
Hear when a new Acute Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.